PFIZERNSEPfizer Limited· PharmaceuticalsLowNeutral
Announced Mon, 19 May · 22:57 IST

Pfizer Limited has informed the Exchange about appointment of M/s. Kishore Bhatia & Associates as the Cost Auditors of the Company for the financial year ending March 31, 2026. The Board of Directors also appointed M/s. Parikh & Associates, Company Secretaries as the Secretarial Auditors of the Company for a term of 5 (five) consecutive financial years commencing from financial year 2025-26 to financial year 2029-30, subject to approval by the Members at the ensuing Annual General Meeting of the Company.

Management Changes View source PDF

PFIZER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Pfizer Limited has appointed M/s. Kishore Bhatia & Associates as Cost Auditors for the financial year ending March 31, 2026. Additionally, M/s. Parikh & Associates, Company Secretaries, have been appointed as Secretarial Auditors for a 5-year term covering FY 2025-26 to FY 2029-30. Both appointments were made by the Board of Directors on May 19, 2025, following the recommendation of the Audit Committee. The Secretarial Auditor appointment requires shareholder approval at the upcoming Annual General Meeting, while the remuneration for Cost Auditors will be placed before shareholders for ratification. Neither firm has any relationship with the company's Directors.

Likely market impact

This is a routine regulatory compliance disclosure with no material impact on the stock price or shareholders. It reflects standard governance practice of appointing auditors as required under Indian company law.